BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34912397)

  • 21. [Application of short-tandem-repeat amplification and fluorescent-multiplex PCR for chimerism analysis].
    Li SX; Zhu HL; Guo B; Da WM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):749-53. PubMed ID: 21729564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-time PCR for monitoring minimal residual disease and chimerism in patients after allogeneic transplantation.
    Elmaagacli AH
    Int J Hematol; 2002 Aug; 76 Suppl 2():204-5. PubMed ID: 12430926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chimerism monitoring after allogeneic hematopoietic stem cell transplantation using quantitative real-time PCR of biallelic insertion/deletion polymorphisms.
    Kim SY; Jeong MH; Park N; Ra E; Park H; Seo SH; Kim JY; Seong MW; Park SS
    J Mol Diagn; 2014 Nov; 16(6):679-88. PubMed ID: 25157970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous Monitoring of Mutation and Chimerism Using Next-Generation Sequencing in Myelodysplastic Syndrome.
    Lee JM; Kim YJ; Park SS; Han E; Kim M; Kim Y
    J Clin Med; 2019 Nov; 8(12):. PubMed ID: 31795155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Utility of Quantitative PCR for Chimerism and Engraftment Monitoring after Allogeneic Stem Cell Transplantation for Hematologic Malignancies.
    Ahci M; Stempelmann K; Buttkereit U; Crivello P; Trilling M; Heinold A; Steckel NK; Koldehoff M; Horn PA; Beelen DW; Fleischhauer K
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1658-1668. PubMed ID: 28603070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A strategy for single nucleotide polymorphism analysis of chimerism for somatic cell therapy.
    Chen X; Hofmann TJ; Otsuru S; Jethva R; Lind C; Monos D; Horwitz EM
    Cytotherapy; 2010 Dec; 12(8):1035-43. PubMed ID: 20429790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of early chimerism status on clinical outcome in children with acute lymphoblastic leukaemia after haematopoietic stem cell transplantation.
    Lejman M; Zaucha-Prażmo A; Zawitkowska J; Mroczkowska A; Grabowski D; Kowalczyk JR; Drabko K
    BMC Cancer; 2019 Nov; 19(1):1141. PubMed ID: 31771553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microfluidic chip-based assay for post-hematopoietic stem cell transplantation chimerism monitoring using polymorphic tandem repeat markers.
    Daud SS; Ibrahim K; Choong SS; Vengidasan L; Chong LA; Ariffin H
    Anal Biochem; 2010 Feb; 397(2):181-5. PubMed ID: 19822126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance characteristics of chimerism testing by next generation sequencing.
    Cusick MF; Clark L; Tu T; Goforth J; Zhang X; LaRue B; Gutierrez R; Jindra PT
    Hum Immunol; 2022 Jan; 83(1):61-69. PubMed ID: 34728094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA.
    Mackinnon S; Barnett L; Bourhis JH; Black P; Heller G; O'Reilly RJ
    Blood; 1992 Dec; 80(12):3235-41. PubMed ID: 1467526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultra-Sensitive Droplet Digital PCR for the Assessment of Microchimerism in Cellular Therapies.
    Kliman D; Castellano-Gonzalez G; Withers B; Street J; Tegg E; Mirochnik O; Lai J; Clancy L; Gottlieb D; Blyth E
    Biol Blood Marrow Transplant; 2018 May; 24(5):1069-1078. PubMed ID: 29305193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishing the method of chimerism monitoring after allogeneic stem cell transplantation using multiplex polymerase chain reaction amplification of short tandem repeat markers and Amelogenin.
    Sufliarska S; Minarik G; Horakova J; Bodova I; Bojtarova E; Czako B; Mistrik M; Drgona L; Demitrovicova M; Lakota J; Krivosikova M; Kovacs L
    Neoplasma; 2007; 54(5):424-30. PubMed ID: 17688372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT.
    Mansouri M; Villard J; Ramzi M; Alavianmehr A; Farjadian S
    Hum Immunol; 2020 Jun; 81(6):285-292. PubMed ID: 32199702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring of hematopoietic chimerism by real-time quantitative PCR of micro insertions/deletions in samples with low DNA quantities.
    Bach C; Tomova E; Goldmann K; Weisbach V; Roesler W; Mackensen A; Winkler J; Spriewald BM
    Transfus Med Hemother; 2015 Jan; 42(1):38-45. PubMed ID: 25960714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring of chimerism following allogeneic haematopoietic stem cell transplantation (HSCT): technical recommendations for the use of short tandem repeat (STR) based techniques, on behalf of the United Kingdom National External Quality Assessment Service for Leucocyte Immunophenotyping Chimerism Working Group.
    Clark JR; Scott SD; Jack AL; Lee H; Mason J; Carter GI; Pearce L; Jackson T; Clouston H; Sproul A; Keen L; Molloy K; Folarin N; Whitby L; Snowden JA; Reilly JT; Barnett D;
    Br J Haematol; 2015 Jan; 168(1):26-37. PubMed ID: 25145701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chimerism in pediatric hematopoietic stem cell transplantation and its correlation with the clinical outcome.
    Gabr H; Youssry I; El-Ansary Y; Mosallam G; Riad NM; Hanna MOF
    Transpl Immunol; 2017 Dec; 45():53-58. PubMed ID: 28951259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma.
    Kröger N; Zagrivnaja M; Schwartz S; Badbaran A; Zabelina T; Lioznov M; Ayuk F; Zander A; Fehse B
    Exp Hematol; 2006 May; 34(5):688-94. PubMed ID: 16647575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of chimerism and early engraftment after allogeneic peripheral blood stem cell or bone marrow transplantation by short tandem repeats.
    Frankel W; Chan A; Corringham RE; Shepherd S; Rearden A; Wang-Rodriguez J
    Am J Hematol; 1996 Aug; 52(4):281-7. PubMed ID: 8701946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practical informativeness of short tandem repeat loci for chimerism analysis in hematopoietic stem cell transplantation.
    Han E; Kim M; Kim Y; Han K; Lim J; Kang D; Lee GD; Kim JR; Lee JW; Chung NG; Cho B; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Min CK; Kim DW; Lee J; Min WS
    Clin Chim Acta; 2017 May; 468():51-59. PubMed ID: 28192074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the sensitivity of two recently developed STR multiplexes for the analysis of chimerism after haematopoietic stem cell transplantation.
    Odriozola A; Riancho JA; Colorado M; Zarrabeitia MT
    Int J Immunogenet; 2013 Apr; 40(2):88-92. PubMed ID: 22594517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.